We are live on ! Find out more
OFIX icon

Orthofix Medical

136 hedge funds and large institutions have $519M invested in Orthofix Medical in 2024 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 44 increasing their positions, 55 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

2% more capital invested

Capital invested by funds: $511M → $519M (+$7.96M)

7.54% less ownership

Funds ownership: 103.17%95.62% (-7.5%)

13% less funds holding

Funds holding: 156136 (-20)

20% less repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 55

47% less call options, than puts

Call options by funds: $40K | Put options by funds: $75K

69% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 26

Holders
136
Holders Change
-20
Holders Change %
-12.82%
% of All Funds
1.96%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
8
Increased
44
Reduced
55
Closed
26
Calls
$40K
Puts
$75K
Net Calls
-$35K
Net Calls Change
-$35K
Name Holding Trade Value Shares
Change
Change in
Stake
GCP
51
GSA Capital Partners
United Kingdom
$921K +$877K +63,412 New
Connor, Clark & Lunn Investment Management (CC&L)
52
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$890K -$1.03M -74,780 -55%
JF
53
Jump Financial
Illinois
$860K -$664K -47,997 -45%
GSIS
54
Global Strategic Investment Solutions
Arizona
$838K
RhumbLine Advisers
55
RhumbLine Advisers
Massachusetts
$832K -$5.79K -419 -0.7%
KTA
56
Keeley-Teton Advisors
Illinois
$731K
FP
57
Factorial Partners
New York
$701K -$83K -6,000 -11%
American Century Companies
58
American Century Companies
Missouri
$690K +$168K +12,117 +34%
Bank of America
59
Bank of America
North Carolina
$676K -$695K -50,249 -52%
JP Morgan Chase
60
JP Morgan Chase
New York
$674K +$135K +9,761 +27%
HighTower Advisors
61
HighTower Advisors
Illinois
$669K -$180K -13,020 -22%
Ameriprise
62
Ameriprise
Minnesota
$657K -$1.13M -81,530 -64%
CS
63
Credit Suisse
Switzerland
$603K -$4.44K -321 -0.8%
UBS AM
64
UBS AM
Illinois
$560K +$65.3K +4,721 +14%
UBS Group
65
UBS Group
Switzerland
$554K -$438K -31,714 -45%
SEI Investments
66
SEI Investments
Pennsylvania
$538K -$24.3K -1,760 -5%
AllianceBernstein
67
AllianceBernstein
Tennessee
$531K -$35.3K -2,550 -7%
TCWA
68
Turtle Creek Wealth Advisors
Texas
$510K
BNP Paribas Financial Markets
69
BNP Paribas Financial Markets
France
$502K +$314K +22,690 +190%
CFM
70
Catalyst Funds Management
Australia
$495K +$471K +34,100 New
California State Teachers Retirement System (CalSTRS)
71
California State Teachers Retirement System (CalSTRS)
California
$483K -$72.7K -5,255 -14%
T. Rowe Price Associates
72
T. Rowe Price Associates
Maryland
$479K +$17.1K +1,236 +4%
Boston Partners
73
Boston Partners
Massachusetts
$478K
Amundi
74
Amundi
France
$477K +$473K +34,241 +1,418%
Legal & General Group
75
Legal & General Group
United Kingdom
$464K

OFIX Hedge Fund Activity: Q1 2024 in Review

136 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Orthofix Medical (OFIX) for Q1 2024, worth a combined $519M — up 1.6% from $511M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of OFIX and 8 opened new positions — a net loss of 18 holders — while 55 trimmed existing stakes and 44 added.

The largest buyer was Paradigm Capital Management Inc, adding an estimated $14M. The largest seller was Morgan Stanley, cutting an estimated $19.7M.

  • 136 institutional investors held Orthofix Medical (OFIX) as of Q1 2024, down from 156 in Q4 2023.
  • Funds reported $519M of Orthofix Medical stock for Q1 2024, up 1.6% quarter-over-quarter.
  • 8 funds opened new Orthofix Medical positions in Q1 2024 and 26 closed out, a net change of -18 holders.
  • The largest Orthofix Medical buyer in Q1 2024 was Paradigm Capital Management Inc, an estimated $14M added.
  • The largest Orthofix Medical seller in Q1 2024 was Morgan Stanley, an estimated $19.7M sold.

Based on aggregated 13F filings for Q1 2024.